More BTC pseudoephedrine
This article was originally published in The Tan Sheet
Executive Summary
Medicine Shoppe is restricting sale of pseudoephedrine products to behind the pharmacy counter, the St. Louis-based firm announces May 23. The move of single-ingredient, solid-dose pseudoephedrine cold products takes effect in all company-owned Medicine Shoppe Pharmacies and Medicap Pharmacy stores June 1, the firm says. Franchised stores are not required to make the move unless otherwise dictated by state laws, but are encouraged to take measures to prevent the products' diversion to meth production, the company notes. Several retailers, including CVS and Rite Aid, said in May they would move pseudoephedrine behind the counter (1"The Tan Sheet" May 2, 2005, p. 4)...
You may also be interested in...
Retailers Put Pseudoephedrine Behind Counters, Lend Weight To Talent Bill
A wave of decisions from leading OTC drug retailers to place pseudoephedrine solids behind the counter could provide momentum for a federal pseudoephedrine BTC bill
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.